Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study. (August 2022)
- Record Type:
- Journal Article
- Title:
- Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study. (August 2022)
- Main Title:
- Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study
- Authors:
- Barutta, Federica
Bellini, Stefania
Guarrera, Simonetta
Matullo, Giuseppe
Schalkwijk, Casper
Stehouwer, Coen D.
Chaturvedi, Nish
Soedamah-Muthu, Sabita S.
Durazzo, Marilena
Gruden, Gabriella - Abstract:
- Abstract: Aims: To investigate whether serum miR-145-5p levels were associated with micro-macrovascular chronic complications in patients with type 1 diabetes (DM1). Methods: A nested case-control study from the EURODIAB Prospective Complications Study was performed. Cases ( n = 289) had one or more complications of diabetes, whereas controls ( n = 153) did not have any complication. We measured miR-145-5p levels by qPCR and investigated the association with diabetes complications. Results: Mean miR-145-5p levels were significantly lower in cases with microangiopathy [2.12 (0.86–4.94)] compared to controls [3.15 (1.21–7.36), P < 0.05] even after adjustment for age, gender, and diabetes duration. In logistic regression analysis, miR-145-5p levels in the lowest tertile were associated with an over three-fold increased odds ratio (OR) of albuminuria [3.22 (1.17–8.81)], independently of both demographic and diabetes-related factors. In addition, mir145-5p levels in the lowest tertile were independently and inversely associated with arterial hypertension [1.96 (1.08–3.56)] and hypertension was the mediator of the relationship between miR-145-5p and albuminuria. Conclusions: In this large cohort of DM1 patients, we found an inverse association between miR-145-5p and albuminuria that was mediated by systemic hypertension.
- Is Part Of:
- Diabetes research and clinical practice. Volume 190(2022)
- Journal:
- Diabetes research and clinical practice
- Issue:
- Volume 190(2022)
- Issue Display:
- Volume 190, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 190
- Issue:
- 2022
- Issue Sort Value:
- 2022-0190-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08
- Subjects:
- Type 1 diabetes -- microRNAs -- Diabetic complications -- Cardiovascular diseases -- Hypertension -- Albuminuria -- Diabetic nephropathy -- Diabetic kidney disease -- TGF-β1
Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.diabres.2022.109987 ↗
- Languages:
- English
- ISSNs:
- 0168-8227
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23288.xml